Equels Thomas K's Form 4 filing
AIM ImmunoTech Inc. (AIM) · filed May 7, 2024
- Accession no.
- 0001493152-24-018030
- Filed
- May 7, 2024, 8:30 AM ET
- Trade date
- May 6, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $25.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Equels Thomas KCIK 0001450324 | Director, Officer (CEO & President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Common Stock | PPurchaseAcquired | +61,729 | $0.405 | +$25,000.25 | 778,184 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.